Long-term impact of hepatitis B, C virus infection on renal transplantation

American Journal of Nephrology

Volumn 21, Issue 4, 2001, Pages 300-306

  Lee, Wen Chin ^a   Shu, Kuo Hsiung ^a,b   Cheng, Chi Hung ^a   Wu, Ming Ju ^a   Chen, Cheng Hsu ^a   Lian, Jong Da ^b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Renal transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DEATH; EVALUATION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HERPES VIRUS INFECTION; HUMAN; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NEOPLASMS; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034889844     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046265     Document Type: Article

References (32)

1. Long-term results and complications in renal transplant recipients
2. Liver disease in renal transplant recipients
3. Long-term effect of HBs antigenemia on patient survival after renal transplantation
4. The clinical outcome of hepatitis C virus Ab-positive renal allograft recipients
5. The impact of hepatitis C virus infection on renal allograft recipients
6. Hepatitis B and C in renal transplantation in Taiwan
7. Hepatitis B disease in dialysis and transplant patients: Further, epidemiologic and serologic studies
8. Hepatitis in patients with end stage renal disease
9. Dialysis therapy in Taiwan: 1995 National surveillance report
10. Noninvasive imaging of the liver and biliary system
11. Primary liver cell carcinoma
12. Hepatitis C virus infection among kidney transplant recipients
13. Hepatitis C infection in two urban hemodialysis units
14. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years
15. Prevention of hepatitis B and C virus infection for prevention of cirrhosis and hepatocellular carcinoma
16. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B positive and B negative renal transplant recipients
17. Hepatitis B surface antigenemia in renal transplant recipients
18. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients
19. Renal transplantation is not contraindicated in hepatitis B surface antigen positive patients
20. Early detection of hepatocellular carcinoma in hepatitis B-positive renal transplant recipients
21. Chronic hepatitis in kidney allograft recipients
22. Impact of hepatitis B or C infection on the practice of kidney transplantation in the United States
23. Impact of hepatitis B and C virus on kidney transplantation outcome
24. Hepatitis C - Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation
25. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
26. Malignancy
27. Malignancy following renal transplantation
28. Tumors of the liver and biliary tract
29. Dominant replication of either virus in dual infection with hepatitis virus B and C
30. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis
31. Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection
32. The impact of renal transplantation on survival in hepatitis C positive end stage renal disease patients